[1] Napolioni V, Curatolo P. Genetics and molecular biology of tuberous sclerosis comple[J]. Curr Genomics., 2008, 9：475-487.
[2] Cheadle JP, Reeve MP, Sampson JR, et al. Molecular genetic advances in tuberous sclerosis[J]. Hum Genet, 2000, 107：97-114.
[3] European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16[J]. Cell, 1993, 75：1305-1135.
[4] Sancak O, Nellist M, Goedbloed M, et al. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting：genotype-phenotype correlations and comparison of diagnostic DNA techniques in tuberous sclerosis complex[J]. Eur J Hum Genet, 2005, 13：731-741.
[5] Jones AC, Shyamsundar MM, Thomas MW, et al. Comprehensive mutation analysis of TSC1 and TSC2 and phenotypic correlations in 150 families with tuberous sclerosis[J]. Am J Hum Genet, 1999, 64：1305-1315.
[6] Lee DF, Kuo HP, Chen CT, et al. IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway[J]. Cell, 2007, 130：440-455.
[7] Gan B, Melkoumian ZK, Wu X, et al. Guan JL. Identification of FIP200 interaction with the TSC1-TSC2 complex and its role in regulation of cell size control[J]. J Cell Biol, 2005, 170：379-389.
[8] Mak BC, Kenerson HL, Aicher LD, et al. Aberrant beta-catenin signaling in tuberous sclerosis[J]. Am J Pathol, 2005, 167：107-116.
[9] Astrinidis A, Senapedis W, Coleman TR, et al. Cell cycle-regulated phosphorylation of hamartin, the product of the tuberous sclerosis complex 1 gene, by cyclin-dependent kinase 1/cyclin B[J]. J Biol Chem, 2003, 278：51372-51379.
[10] Lamb RF, Roy C, Diefenbach TJ, et al. The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho[J]. Nat Cell Biol, 2000, 2：281-287.
[11] Haddad LA, Smith N, Bowser M, et al. The TSC1 tumor suppressor hamartin interacts with neurofilament-L and possibly functions as a novel integrator of the neuronal cytoskeleton[J]. J Biol Chem, 2002, 277：44180-44186.
[12] Inoki K, Ouyang H, Zhu T, et al. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth[J]. Cell, 2006, 126：955-968.
[13] Im E, von Lintig FC, Chen J, et al. Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cells[J]. Oncogene, 2002, 21：6356-6365.
[14] Karbowniczek M, Cash T, Cheung M, et al. Regulation of B-Raf kinase activity by tuberin and Rheb is mammalian target of rapamycin（mTOR）-independent[J]. J Biol Chem, 2004, 279：29930-29937.
[15] Xiao GH, Shoarinejad F, Jin F, et al. The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein（GAP）in modulating endocytosis[J]. J Biol Chem, 1997, 272：6097-6100.
[16] Ghosh S, Tergaonkar V, Rothlin CV, et al. Essential role of tuberous sclerosis genes TSC1 and TSC2 in NF-kappaB activation and cell survival[J]. Cancer Cell, 2006, 10：215-226.
[17] Li Y, Inoki K, Guan KL. Biochemical and functional characteriza-tions of small GTPase Rheb and TSC2 GAP activity[J]. Mol Cell Biol, 2004, 24：7965-7975.
[18] Niida Y, Stemmer-Rachamimov AO, Logrip M, et al. Survey of somatic mutations in tuberous sclerosis complex（TSC）hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions[J]. Am J Hum Genet, 2001, 69：493-503.
[19] Dufner A, Andjelkovic M, Burgering BMT, et al. Protein kinase B localization and activation differentially affect S6 kinase1 activity and eukaryotic translation initiation factor 4E-binding protein1 phosphorylation[J]. Mol Cell Biol, 1999, 19：4525-4534.
[20] Alessi DR, James SR, Downes CP, et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha[J]. Curr Biol, 1997, 7：261-269.
[21] Inoki K, Li Y, Zhu T, et al. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signaling[J]. Nat Cell Biol, 2002, 4：648-657.
[22] Potter CJ, Pedraza LG, Xu T. Akt regulates growth by directly phosphorylating Tsc2[J]. Nat Cell Biol, 2002, 4：658-665. |
